Information Journal Paper
APA:
Copy. (2017). Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatric nephrology, 32(7), 1221-1232. SID. https://sid.ir/paper/783192/en
Vancouver:
Copy. Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatric nephrology[Internet]. 2017;32(7):1221-1232. Available from: https://sid.ir/paper/783192/en
IEEE:
Copy, “Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease,” Pediatric nephrology, vol. 32, no. 7, pp. 1221–1232, 2017, [Online]. Available: https://sid.ir/paper/783192/en